CXCL1 Clone Evolution Induced by the HDAC Inhibitor Belinostat Might Be a Favorable Prognostic Indicator in Triple-Negative Breast Cancer

<div>Prognostic value and expression of CXCL1 in breast cancer: (a) Kaplan-Meier survival curves for the association of the secretion of CXCL1 with overall survival; (b) expression of CXCL1 in BRCA based on different subclasses.</div>

BioMed Research International

fig5

Figure 5

Figure 5: CXCL1 Clone Evolution Induced by the HDAC Inhibitor Belinostat Might Be a Favorable Prognostic Indicator in Triple-Negative Breast Cancer 